Consun Pharmaceutical reports active share repurchases, plans cancellations

Consun Pharmaceutical Group Limited announced extensive share repurchase activities in its Next Day Disclosure Return submitted on November 18, 2025. The company's opening balance of issued shares (excluding treasury shares) as of November 14, 2025, was 847,983,407, remaining unchanged by the closing balance date of November 17, 2025.

The report details numerous daily share repurchases for cancellation between October 14, 2025, and November 17, 2025. On November 17, 2025, the company repurchased 170,000 shares on the Exchange at a volume-weighted average price of HKD 14.8379. The highest repurchase price for the day was HKD 14.9, and the lowest was HKD 14.67, with an aggregate price paid of HKD 2,522,450. These 170,000 shares are designated for cancellation.

Cumulatively, as of November 17, 2025, the total number of shares authorized for repurchase under the mandate granted on May 22, 2025, is 85,126,334. Consun Pharmaceutical has repurchased 10,168,000 shares on the Exchange, representing 11.9446% of its issued shares as of the mandate date. The moratorium period for issuing new shares or transferring treasury shares after these repurchases extends up to December 17, 2025.